Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Sanntidsoppdatering for Leap Therapeutics Inc [LPTX]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-20)

Expected move: +/- 14.57%

BUY
100.00%
return 10.47%
SELL
0.00%
return 11.12%
Sist oppdatert17 mai 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

-4.01% $ 2.63

SELG 145314 min ago

@ $3.52

Utstedt: 8 feb 2024 @ 20:59

Avkastning: -25.28%

Forrige signal: feb 7 - 21:44

Forrige signal: Kjøp

Avkastning: 2.03 %

Live Chart Being Loaded With Signals

Commentary (17 mai 2024 @ 22:00):

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers...

Stats
Dagens volum 375 785
Gjennomsnittsvolum 307 798
Markedsverdi 100.64M
EPS $0 ( 2024-05-13 )
Neste inntjeningsdato ( $-0.570 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.660
ATR14 $0.0230 (0.87%)
Insider Trading
Date Person Action Amount type
2024-04-10 Gilead Sciences, Inc. Sell 0 Common Stock
2024-01-29 Mashiach Nissim Buy 25 000 Stock Option (Right to Buy)
2024-01-29 Dietz Thomas John Buy 30 000 Stock Option (Right to Buy)
2024-01-29 Schilsky Richard Buy 25 000 Stock Option (Right to Buy)
2024-01-29 Granfield Christine Buy 85 000 Employee Stock Option (Right to Buy)
INSIDER POWER
66.43
Last 95 transactions
Buy: 10 825 606 | Sell: 1 768 106

Volum Korrelasjon

Lang: 0.14 (neutral)
Kort: -0.76 (moderate negative)
Signal:(53.092) Neutral

Leap Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Leap Therapeutics Inc Korrelasjon - Valuta/Råvare

The country flag 0.52
( weak )
The country flag 0.44
( neutral )
The country flag 0.00
( neutral )
The country flag 0.61
( weak )
The country flag 0.29
( neutral )
The country flag 0.47
( neutral )

Leap Therapeutics Inc Økonomi

Annual 2023
Omsetning: $0
Bruttogevinst: $-427 000 (0.00 %)
EPS: $-3.98
FY 2023
Omsetning: $0
Bruttogevinst: $-427 000 (0.00 %)
EPS: $-3.98
FY 2022
Omsetning: $0
Bruttogevinst: $-415 000 (0.00 %)
EPS: $-4.82
FY 2021
Omsetning: $1.50M
Bruttogevinst: $1.50M (100.00 %)
EPS: $-0.470

Financial Reports:

No articles found.

Leap Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Leap Therapeutics Inc

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.